Analytical Data
-
Gene name
ERVFRD-1
- Application
-
Alternative Names
Endogenous retrovirus group FRD member 1;Envelope polyprotein;HERV-FRD;HERV-FRD_6p24.1 provirus ancestral Env polyprotein;SU;TM
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P60508
-
Expression Region
16-350aa
-
AA Sequence
Endogenous retrovirus group FRD member 1;Envelope polyprotein;HERV-FRD;HERV-FRD_6p24.1 provirus ancestral Env polyprotein;SU;TM
-
Molecular Weight
38.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ERVFRD-1, a recombinant protein derived from the Endogenous Retrovirus Family, has garnered significant research interest due to its potential role in understanding various biological processes and diseases. Endogenous retroviruses are remnants of ancient viral infections that have integrated into the host genome, influencing immune responses and cellular functions. Recent studies suggest that ERVFRD-1 may be involved in the regulation of gene expression, immune modulation, and may even play a role in cancer biology. Researchers are particularly intrigued by its potential applications in developing novel therapeutic strategies and biomarkers for diseases linked to immune dysfunction and viral oncogenesis. The ongoing investigation into ERVFRD-1 is aimed at deciphering its molecular mechanisms and therapeutic potentials, which could lead to advancements in clinical approaches for various pathologies. Moreover, understanding ERVFRD-1's implications could further elucidate the evolutionary dynamics of retroviral elements and their contribution to human health.
